SENATE BILL 94
J1 5lr1471
(PRE–FILED) CF HB 553
By: Senator Ellis
Requested: October 29, 2024
Introduced and read first time: January 8, 2025
Assigned to: Finance
Committee Report: Favorable with amendments
Senate action: Adopted with floor amendments
Read second time: February 7, 2025
CHAPTER ______
1 AN ACT concerning
2 Maryland Medical Assistance Program – Maternal Health Self–Measured Blood
3 Pressure Monitoring
4 FOR the purpose of requiring, beginning on a certain date, the Maryland Medical
5 Assistance Program to provide coverage for self–measured blood pressure
6 monitoring for certain eligible Program recipients; requiring the Program to develop
7 and implement a certain education campaign; and generally relating to
8 self–measured blood pressure monitoring under the Maryland Medical Assistance
9 Program.
10 BY repealing and reenacting, without amendments,
11 Article – Health – General
12 Section 15–101(h), (j), and (l) and 15–103(a)(1)
13 Annotated Code of Maryland
14 (2023 Replacement Volume and 2024 Supplement)
15 BY repealing and reenacting, with amendments,
16 Article – Health – General
17 Section 15–103(a)(2)(xxiii) and (xxiv)
18 Annotated Code of Maryland
19 (2023 Replacement Volume and 2024 Supplement)
20 BY adding to
21 Article – Health – General
EXPLANATION: CAPITALS INDICATE MATTER ADDED TO EXISTING LAW.
[Brackets] indicate matter deleted from existing law.
Underlining indicates amendments to bill.
Strike out indicates matter stricken from the bill by amendment or deleted from the law by
amendment. *sb0094*

2 SENATE BILL 94
1 Section 15–103(a)(2)(xxv) and 15–141.6
2 Annotated Code of Maryland
3 (2023 Replacement Volume and 2024 Supplement)
4 SECTION 1. BE IT ENACTED BY THE GENERAL ASSEMBLY OF MARYLAND,
5 That the Laws of Maryland read as follows:
6 Article – Health – General
7 15–101.
8 (h) “Program” means the Maryland Medical Assistance Program.
9 (j) “Self–measured blood pressure monitoring” means the regular measurement
10 of blood pressure by the patient outside the clinical setting, either at home or elsewhere,
11 requiring the use of a home blood pressure measurement device by the patient.
12 (l) “Validated home blood pressure monitor” means a blood pressure
13 measurement device that has been validated for accuracy and is listed in the U.S. Blood
14 Pressure Validated Device Listing.
15 15–103.
16 (a) (1) The Secretary shall administer the Maryland Medical Assistance
17 Program.
18 (2) The Program:
19 (xxiii) Beginning on July 1, 2025, shall provide, subject to the
20 limitations of the State budget, and as permitted by federal law, coverage for biomarker
21 testing in accordance with § 15–859 of the Insurance Article; [and]
22 (xxiv) Beginning on January 1, 2025, shall provide coverage for
23 prostheses in accordance with § 15–844 of the Insurance Article; AND
24 (XXV) BEGINNING ON JANUARY 1, 2026, SHALL PROVIDE,
25 SUBJECT TO THE LIMITATIONS OF THE STATE BUDGET, AND AS PERMITTED BY
26 FEDERAL LAW, COVERAGE FOR SELF–MEASURED BLOOD PRESSURE MONITORING
27 FOR ELIGIBLE PROGRAM RECIPIENTS IN ACCORDANCE WITH § 15–141.6 OF THIS
28 SUBTITLE.
29 15–141.6.
30 (A) (1) IN THIS SECTION THE FOLLOWING WORDS HAVE THE MEANINGS
31 INDICATED.

SENATE BILL 94 3
1 (2) “ELIGIBLE PROGRAM, “ELIGIBLE PROGRAM RECIPIENT” MEANS
2 A PROGRAM RECIPIENT WHO:
3 (I) (1) IS PREGNANT;
4 (II) (2) IS POSTPARTUM; OR
5 (III) (3) HAS BEEN DIAGNOSED WITH:
6 1. (I) CHRONIC KIDNEY DISEASE;
7 2. (II) DIABETES;
8 3. (III) HEART DISEASE; OR
9 4. (IV) A CARDIOMETABOLIC DISEASE.
10 (3) “HEALTH CARE PROVIDER” MEANS:
11 (I) A PERSON WHO IS LICENSED, CERTIFIED, OR OTHERWISE
12 AUTHORIZED UNDER THE HEALTH OCCUPATIONS ARTICLE TO PROVIDE HEALTH
13 CARE IN THE ORDINARY COURSE OF BUSINESS OR PRACTICE OF A PROFESSION, OR
14 IN AN APPROVED EDUCATION OR TRAINING PROGRAM; OR
15 (II) A COMMUNITY HEALTH WORKER CERTIFIED UNDER TITLE
16 13, SUBTITLE 37 OF THIS ARTICLE.
17 (B) THE PROGRAM SHALL PROVIDE COVERAGE FOR SELF–MEASURED
18 BLOOD PRESSURE MONITORING FOR ALL ELIGIBLE PROGRAM RECIPIENTS,
19 INCLUDING:
20 (1) THE PROVISION OF VALIDATED HOME BLOOD PRESSURE
21 MONITORS; AND
22 (2) REIMBURSEMENT OF HEALTH CARE PROVIDER AND OTHER STAFF
23 TIME USED FOR PATIENT TRAINING, TRANSMISSION OF BLOOD PRESSURE DATA,
24 INTERPRETATION OF BLOOD PRESSURE READINGS AND REPORTING, REMOTE
25 PATIENT MONITORING, AND THE DELIVERY OF CO–INTERVENTIONS, INCLUDING
26 EDUCATIONAL MATERIALS OR CLASSES.
27 (C) THE PROGRAM SHALL DEVELOP AND IMPLEMENT AN EDUCATION
28 CAMPAIGN TO INFORM ELIGIBLE PROGRAM RECIPIENTS AND HEALTH CARE
29 PROVIDERS ABOUT THE BENEFITS AND USAGE OF BLOOD PRESSURE MONITORING

4 SENATE BILL 94
1 TECHNOLOGY AND THE AVAILABILITY OF ASSISTANCE WITH SETUP AND
2 TROUBLESHOOTING.
3 (D) ON OR BEFORE DECEMBER 1 EACH YEAR, BEGINNING IN 2027, THE
4 DEPARTMENT SHALL SUBMIT A REPORT TO THE SENATE FINANCE COMMITTEE AND
5 THE HOUSE HEALTH AND GOVERNMENT OPERATIONS COMMITTEE, IN
6 ACCORDANCE WITH § 2–1257 OF THE STATE GOVERNMENT ARTICLE, THAT
7 INCLUDES:
8 (1) THE TOTAL NUMBER OF ELIGIBLE PROGRAM RECIPIENTS WHO
9 RECEIVED BLOOD PRESSURE MONITORS UNDER THIS SECTION DURING THE
10 IMMEDIATELY PRECEDING 12–MONTH PERIOD;
11 (2) THE OUTCOMES ASSOCIATED WITH THE USE OF THE HOME BLOOD
12 PRESSURE MONITORS UNDER THIS SECTION; AND
13 (3) ANY COST SAVINGS ACHIEVED BY THE PROGRAM DURING THE
14 IMMEDIATELY PRECEDING FISCAL YEAR ASSOCIATED WITH THE USE OF THE HOME
15 BLOOD PRESSURE MONITORS DISTRIBUTED IN ACCORDANCE WITH THIS SECTION.
16 SECTION 2. AND BE IT FURTHER ENACTED, That this Act shall take effect July
17 1, 2025.
Approved:
________________________________________________________________________________
Governor.
________________________________________________________________________________
President of the Senate.
________________________________________________________________________________
Speaker of the House of Delegates.

[DELETED: :CA      5 ( C A M P F t p o r b o a c d t M M A P t p c f s b p m a i a c e c a g r t s P B  A S  A  ( B  A S  A  ( B  A]
[DELETED:  S  S  A  (  S T A 1  ( “  ( “ o r  ( “ h b p m m a b p m P 1  ( ( T S s a t M M A P   ( T    ( o J 1 2 s p s t t l t ad    ( o J 1 2 s p c f pe   )BJ1,2,VE O A   S PE T T L O T T BT A A P BW FM R   §1 .  ) ( N ]
[DELETED: S 3    “EP,“P RM E RMRT  R       )()I S     )()II SM     )( HI A     .()  CIH     .() DIII     .() HIIEE     .() A.IV     “H”R S    ) A, D D  E C RO N  M      ) AI  I,S37U  E  ) TPH R S P C F SFM P M F A E R RSG    P O V H B PS     U F P TG T O B P DA O B P R A RG R MG A T D O COIS I–S  ) TH R S D A I A E T I E R R A H C  ]
[DELETED:  S  A T A O A W S A G   ) OD1,2N O B E  E YR B I  TSF E I O  O E A O P OE IHGOC  W   O T T O RE T27SGA      T T N O E R R W B P M U T S D T  M–     N      A C S A B T R D T N   S 1          G               ]